SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-079813
Filing Date
2021-06-11
Accepted
2021-06-11 07:15:45
Documents
13
Period of Report
2021-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119440d1_8k.htm   iXBRL 8-K 50145
2 EXHIBIT 3.1 tm2119440d1_ex3-1.htm EX-3.1 7247
  Complete submission text file 0001104659-21-079813.txt   239558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20210609.xsd EX-101.SCH 3199
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20210609_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20210609_pre.xml EX-101.PRE 22719
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2119440d1_8k_htm.xml XML 3839
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 211009953
SIC: 2834 Pharmaceutical Preparations